TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Anatara Lifesciences Ltd ( (AU:ANR) ) is now available.
Anatara Lifesciences Ltd announced a change in the director’s interest, with Dr. David Brookes acquiring additional shares through entities Tarandi and Dahlbrook Family Trust. This acquisition, valued at $40,000, reflects a strategic move that could influence the company’s market positioning and stakeholder confidence.
More about Anatara Lifesciences Ltd
Anatara Lifesciences Ltd operates in the biotechnology industry, focusing on developing therapeutic solutions for gastrointestinal diseases. The company is known for its innovative approach to addressing unmet medical needs in both human and animal health markets.
Average Trading Volume: 3,342,970
Technical Sentiment Signal: Sell
Current Market Cap: A$2.97M
For a thorough assessment of ANR stock, go to TipRanks’ Stock Analysis page.